Literature DB >> 24371770

GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation.

Keiko Niimi1, Hitoshi Kiyoi1, Yuichi Ishikawa1, Fumihiko Hayakawa1, Shingo Kurahashi1, Rika Kihara1, Akihiro Tomita1, Tomoki Naoe1.   

Abstract

We identified two novel GATA2 mutations in acute myeloid leukemia (AML). One mutation (p.R308P-GATA2) was a R308P substitution within the zinc finger (ZF)-1 domain, and the other (p.A350_N351ins8-GATA2) was an eight-amino-acid insertion between A350 and N351 residues within the ZF-2 domain. p.R308P-GATA2 did not affect DNA-binding and transcriptional activities, while p.A350_N351ins8-GATA2 reduced them, and impaired G-CSF-induced granulocytic differentiation of 32D cells. Although p.A350_N351ins8-GATA2 did not show a dominant-negative effect over wild-type (Wt)-GATA2 by the reporter assay, it might be involved in the pathophysiology of AML by impairing myeloid differentiation because of little Wt-GATA2 expression in primary AML cells harboring the p.A350_N351ins8 mutation.

Entities:  

Keywords:  AML; Differentiation; GATA2; Mutation

Year:  2013        PMID: 24371770      PMCID: PMC3850381          DOI: 10.1016/j.lrr.2013.02.002

Source DB:  PubMed          Journal:  Leuk Res Rep        ISSN: 2213-0489


  11 in total

Review 1.  Diversification of haematopoietic stem cells to specific lineages.

Authors:  S H Orkin
Journal:  Nat Rev Genet       Date:  2000-10       Impact factor: 53.242

2.  GATA2 mutations lead to MDS and AML.

Authors:  R Katherine Hyde; P Paul Liu
Journal:  Nat Genet       Date:  2011-09-28       Impact factor: 38.330

3.  A sumoylation site in PML/RARA is essential for leukemic transformation.

Authors:  Jun Zhu; Jun Zhou; Laurent Peres; Florence Riaucoux; Nicole Honoré; Scott Kogan; Hugues de Thé
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

4.  Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.

Authors:  Lidia De Felice; Caterina Tatarelli; Maria Grazia Mascolo; Chiara Gregorj; Francesca Agostini; Roberto Fiorini; Vania Gelmetti; Simona Pascale; Fabrizio Padula; Maria Teresa Petrucci; William Arcese; Clara Nervi
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

5.  Histone deacetylase 3 associates with and represses the transcription factor GATA-2.

Authors:  Y Ozawa; M Towatari; S Tsuzuki; F Hayakawa; T Maeda; Y Miyata; M Tanimoto; H Saito
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

6.  The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs.

Authors:  Sonia Rodriguez; Lin Wang; Christen Mumaw; Edward F Srour; Cristina Lo Celso; Kei-ichi Nakayama; Nadia Carlesso
Journal:  Blood       Date:  2011-04-18       Impact factor: 22.113

7.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).

Authors:  Pia Ostergaard; Michael A Simpson; Fiona C Connell; Colin G Steward; Glen Brice; Wesley J Woollard; Dimitra Dafou; Tatjana Kilo; Sarah Smithson; Peter Lunt; Victoria A Murday; Shirley Hodgson; Russell Keenan; Daniela T Pilz; Ines Martinez-Corral; Taija Makinen; Peter S Mortimer; Steve Jeffery; Richard C Trembath; Sahar Mansour
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

8.  KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.

Authors:  Yukimasa Shiotsu; Hitoshi Kiyoi; Yuichi Ishikawa; Ryohei Tanizaki; Makiko Shimizu; Hiroshi Umehara; Kenichi Ishii; Yumiko Mori; Kazutaka Ozeki; Yosuke Minami; Akihiro Abe; Hiroshi Maeda; Tadakazu Akiyama; Yutaka Kanda; Yuko Sato; Shiro Akinaga; Tomoki Naoe
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

9.  Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.

Authors:  Su-Jiang Zhang; Li-Yuan Ma; Qiu-Hua Huang; Guo Li; Bai-Wei Gu; Xiao-Dong Gao; Jing-Yi Shi; Yue-Ying Wang; Li Gao; Xun Cai; Rui-Bao Ren; Jiang Zhu; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

10.  Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Christopher N Hahn; Chan-Eng Chong; Catherine L Carmichael; Ella J Wilkins; Peter J Brautigan; Xiao-Chun Li; Milena Babic; Ming Lin; Amandine Carmagnac; Young K Lee; Chung H Kok; Lucia Gagliardi; Kathryn L Friend; Paul G Ekert; Carolyn M Butcher; Anna L Brown; Ian D Lewis; L Bik To; Andrew E Timms; Jan Storek; Sarah Moore; Meryl Altree; Robert Escher; Peter G Bardy; Graeme K Suthers; Richard J D'Andrea; Marshall S Horwitz; Hamish S Scott
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

View more
  5 in total

1.  Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.

Authors:  Edgar Borges de Oliveira-Júnior; Jérémie Rosain; Franck Rapaport; Caroline Deswarte; Antoine Guérin; Sairaj Munavar Sajjath; Yu Jerry Zhou; Stéphane Marot; Claire Lozano; Aurélie Cobat; Laurent Abel; Jean-Laurent Casanova; Carmen Oleaga-Quintas; Lidia Branco; Nuria Fernández-Hidalgo; Dukhee Betty Lew; Anne-Sophie Brunel; Caroline Thomas; Elise Launay; Andrés Augusto Arias; Alexis Cuffel; Vanesa Cunill Monjo; Anna-Lena Neehus; Laura Marques; Manon Roynard; Marcela Moncada-Vélez; Bengü Gerçeker; Roger Colobran; Marie-Gabrielle Vigué; Gabriela Lopez-Herrera; Laura Berron-Ruiz; Nora Hilda Segura Méndez; Patricia O'Farrill Romanillos; Tom Le Voyer; Anne Puel; Christine Bellanné-Chantelot; Kacy A Ramirez; Lazaro Lorenzo-Diaz; Noé Ramirez Alejo; Rebeca Pérez de Diego; Antonio Condino-Neto; Fethi Mellouli; Carlos Rodriguez-Gallego; Torsten Witte; José Franco Restrepo; Mariana Jobim; Stéphanie Boisson-Dupuis; Eric Jeziorski; Claire Fieschi; Guillaume Vogt; Jean Donadieu; Marlène Pasquet; Julia Vasconcelos; Fatma Omur Ardeniz; Mónica Martínez-Gallo; Regis A Campos; Luiz Fernando Jobim; Rubén Martínez-Barricarte; Kang Liu; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2021-01-08       Impact factor: 8.317

Review 2.  Haematopoietic and immune defects associated with GATA2 mutation.

Authors:  Matthew Collin; Rachel Dickinson; Venetia Bigley
Journal:  Br J Haematol       Date:  2015-02-23       Impact factor: 6.998

3.  GATA2 deficiency and related myeloid neoplasms.

Authors:  Marcin W Wlodarski; Matthew Collin; Marshall S Horwitz
Journal:  Semin Hematol       Date:  2017-05-10       Impact factor: 3.851

Review 4.  Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Emilia J Kozyra; Marcin W Wlodarski
Journal:  Best Pract Res Clin Haematol       Date:  2020-07-29       Impact factor: 3.020

5.  GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.

Authors:  Feng-Ming Tien; Hsin-An Hou; Cheng-Hong Tsai; Jih-Luh Tang; Yu-Chiao Chiu; Chien-Yuan Chen; Yuan-Yeh Kuo; Mei-Hsuan Tseng; Yen-Ling Peng; Ming-Chih Liu; Chia-Wen Liu; Xiu-Wen Liao; Liang-In Lin; Chien-Ting Lin; Shang-Ju Wu; Bor-Sheng Ko; Szu-Chun Hsu; Shang-Yi Huang; Ming Yao; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Cancer J       Date:  2018-08-31       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.